SHP611
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for SHP611, covering 2024-06-06 to 2024-06-06. Get the full timeline:
Most recent: Clinical Trial Update: A Study of Intrathecal SHP611 in Children With Metachromatic Leukodystrophy [Phase 2]